CUA Urology WebEx Series

From the comfort and convenience of your work or home, we welcome you to come join this important conversation. 

 

TSC related Angiomyolipoma - Management Strategies and Case Studies 

MAY 1, 2019 | 20:00 EST

Featured Speaker: Dr. Anil Kapoor

Professor of Surgery (Urology)
McMaster University

Learning Objectives:

By the end of this program, participants will:
• Review TSC Disease and its manifestations
• Learn how to recognize AMLs Associated with TSC
• Review the Consensus Guidelines and Evidence Supporting the Guidelines
• Discuss patient management options
• Review two “real” life patient cases
• Understand role of TSC CoE in Patient management and when to refer patients/families

SIGN UP HERE >

 *Accredited for Section 1*

 

New treatment options for adults and children with overactive bladder

MAY 29, 2019 | 20:00 EST

Featured Speaker: Dr. Sender Herschorn

Professor of Surgery/Urology
Attending urologist and head of urodynamics Sunnybrook

Learning Objectives:

By the end of this program, participants will:
• Understand the prevalence of OAB and the difference between OAB and other LUTS
• Improve her/his management skills with first and new second line treatment options
• Become familiar with the new CUA OAB Guidelines for selection of pharmacologic treatment

SIGN UP HERE >

*Accredited for Section 1*


ARCHIVED VIDEO RECORDINGS

 

 

What's new in RCC and implications for patients in Canada

 

Debate: In the second line setting, how do you make clinical decisions in tha absence of evidence?

 

Dr. Aly-Khan Lalani | Dr. Anil Kapoor vs. Dr. Sebastien Hotte

 

TSC related Angiomyolipoma - Management Strategies and Case Studies

Dr. Anil Kapoor

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

 

Dr. Scott North & Dr. Anil Kapoor

 

 

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

Dr. Scott North & Dr. Anil Kapoor


Testosterone Suppression in the Treatment of Recurrent or Metastatic Prostate Cancer - A Canadian Consensus Statement 

Dr. Laurie Klotz

 

New Developments in the management of metastatic prostate cancer: A look back at 2017

What is the optimal role for bone targeted therapy in the changing landscape of prostate cancer?

 

Fred Saad
Dr. Anil Kapoor

Live From the CUA: New Developments in the Management of Advanced Prostate Cancer:
Impact on Cancer Care in Canada

Introduction
Dr.Kim Chi
Dr.Alan So and Dr. Fred Saad
Q & A

Present and Future of Prostate Cancer Conventional and Molecular Imaging

 

CUA Webseries: 2015-2016

 

 

The CUA WebEx series is supported by an educational grant from: